Early Life
August Troendle, born January 1, 1956, is a medical doctor who embarked on a career that blended regulatory oversight, pharmaceutical development, and entrepreneurship. He earned his medical degree from the University of Maryland, School of Medicine.
Rise to Success
Troendle's professional journey began with a stint at the Food and Drug Administration (FDA) as a Medical Review Officer. He then transitioned to the pharmaceutical industry, working at Sandoz (now Novartis). In 1992, recognizing a growing need for high-quality clinical research services, Troendle founded Medpace in Cincinnati, Ohio. His vision was to provide comprehensive support to pharmaceutical and biotechnology companies navigating the complex world of clinical trials. Under his leadership, Medpace has grown into a leading CRO, offering a full range of Phase I-IV clinical development services.
Key Business Strategies
Medpace, under Troendle's leadership, is known for its science-driven approach, leveraging in-depth therapeutic expertise to ensure the successful execution of complex clinical trials. The company's mission is to accelerate the global development of safe and effective medical therapeutics. Medpace has enjoyed substantial organic growth, which has solidified its position in the industry and expanded its global footprint. The company's commitment to quality and innovation has been key drivers of Medpace's growth and reputation.
Philanthropy
Beyond his business achievements, Troendle is known for his philanthropic efforts. He supports various charitable initiatives, particularly in education and healthcare, reflecting his commitment to giving back to the community.
